Going PRO: FDA Suggests Best Practices For Choosing, Changing Patient-Reported Outcome Tools
Executive Summary
Patient-Reported Outcome (PRO) instruments are the focus of a 26 January final guidance from the US agency. Sponsors can lean on the guidance when selecting, developing or modifying tools for patient data collection.
You may also be interested in...
FDA Qualifies Facial PRO As New Medical Device Development Tool
The US agency has qualified the FACE-Q | Aesthetics patient-reported outcome instrument through its MDDT program.
FDA Eyeballs Handful Of Emerging Tech Topics For New Medical Device Development Tools
Artificial intelligence, machine learning, and virtual and augmented reality are among the themes under consideration for future MDDTs from the US agency.
Philips Breathing Machines Recall: 21,000+ Adverse Events Reported To FDA In 1 Year
The tens of thousands of Medical Device Reports sent to the US agency included 124 reports of death associated with Philips’ June 2021 recall of millions of BiPAPs, CPAPs, and other mechanical ventilator devices.